Wednesday - September 10, 2025
More than 250 Organizations and Individuals Demand Gilead CEO O'Day Commit to Rapid Application for Regulatory Approval of Long-Acting Lenacapavir for PrEP in all Low- and Middle-Income Countries
August 15, 2025
WASHINGTON, Aug. 15 [Category: Political] -- Public Citizen issued the following news release:

* * *

More than 250 Organizations and Individuals Demand Gilead CEO O'Day Commit to Rapid Application for Regulatory Approval of Long-Acting Lenacapavir for PrEP in all Low- and Middle-Income Countries

*

WASHINGTON, D.C. -- In an open letter sent today to Gilead CEO Daniel O'Day, activists, academics, policy experts, and civil society organi . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products